Celularity ends Rick Gonzalez's role as chief commercial officer
The company's August 5, 2026 filing confirms his departure was immediate, with no successor named in the disclosure.
Celularity Inc. disclosed in an 8-K filing that on August 5, 2026, the company ended Rick Gonzalez's tenure as Chief Commercial Officer, with the change taking effect right away.1 The filing further notes that as of that date, Gonzalez was no longer serving in that role.1
The disclosure was filed under Item 5.02 of Form 8-K, the section covering executive departures, elections, appointments, and related compensatory matters. Celularity is listed as a Delaware corporation headquartered at 170 Park Ave, Florham Park, New Jersey, and trades on Nasdaq under the ticker CELU.
The filing was signed on August 7, 2026 by K. Harold Fletcher, identified as Chief Legal and Strategy Officer. The document does not name a replacement for the Chief Commercial Officer position or provide additional detail on the circumstances of the departure.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.